National Storage Mechanism | Additional information
RNS Number : 3413Z
Willis Towers Watson PLC
20 May 2021
 

Ap9

 

 

APPENDIX 3 DISCLOSURE FORMS

 

 

 

 

 

FORM 8.1(a)&(b)(i)

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

Wilhelm Zeller

Company dealt in

 Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

 Ordinary Shares of $0.000304635 each

Date of dealing

 11 May 2021

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

8,470 ordinary shares

 

 

(2) Derivatives (other than options)

 N/A

 

(3) Options and agreements to purchase/sell

605 RSUs - total amount granted on 11 May 2021 and vesting on earlier of May 11, 2022 and the Issuer's 2022 Annual General Meeting of Shareholders

 

 

Total

9,075 (0.007%)

 

             

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

N/A

 

 

(2) Derivatives (other than options)

N/A

 

 

(3) Options and agreements to purchase/sell

N/A

 

Total

N/A

 

             

 

Ap10

 

 

3.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

 

 

 

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

RSUs

Grant

 605

N/A

N/A

 N/A

N/A

RSUs

Withheld for tax

 687

N/A

N/A

N/A

 US$264.25

RSUs

Vesting

744

N/A

N/A

N/A

N/A

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap11

 

4.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                            YES/NO

 

Date of disclosure

 11 May 2021

Contact name

 Cindy Hanna

Telephone number

+1 (212) 915-7994

Name of offeree/offeror with which acting in concert

 Willis Towers Watson plc

Specify category and nature of acting in concert status

 Director

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEPPUCUAUPGGAU